Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
University of Miami |
---|---|
Information provided by: | University of Miami |
ClinicalTrials.gov Identifier: | NCT00773136 |
Objective: To determine if Lumigan (bimatoprost) causes increased lash length when used in gel suspension applied to the base of the eyelashes. Methods: Subjects recruited from the Bascom Palmer Eye Institute were screened and those who met inclusion criteria were enrolled. Each participant received two vials of gel suspension, which contained bimatoprost and normal saline, respectively, each mixed 1:1 with GonakTM gel and labeled "right eye" and "left eye" according to randomization. The suspension was applied to the eyelashes every evening on the designated eye for 6 weeks. Lash length was measured with a caliper at enrollment, at weekly intervals during the study and at 1 and 3 months after study completion. Visual acuity, ocular symptoms, intraocular pressure and photographs were documented at these same intervals. Results: The average eyelash growth in the Lumigan group was 2.01mm (vs. control average of 1.13mm) which was a statistically significant difference (p=0.009). The average intraocular pressure decreased equally in both groups (2.14 mmHg). No change in visual acuity or iris discoloration was noted in any of the subjects. Discussion: Our data showed an increase in eyelash length with use of Lumigan in gel suspension, suggesting that it may have eyelash lengthening properties.
Condition | Intervention |
---|---|
Eyelash Lengthening |
Drug: Bimatoprost mixed with Gonak into a gel suspension |
Study Type: | Interventional |
Study Design: | Parallel Assignment |
Official Title: | Effect of Bimatoprost (Lumigan) in Gel Suspension Applied to the Eyelashes on Eyelash Growth |
Study Start Date: | February 2008 |
Study Completion Date: | July 2008 |
Primary Completion Date: | July 2008 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
Lumigan Suspension
Each subject was given two suspensions, one mixed with Lumigan and one mixed with normal saline. They were instructed to use the Lumigan suspension to a pre-determined eyelash (prepared prior to study enrollment in double blind fashion).
|
Drug: Bimatoprost mixed with Gonak into a gel suspension |
Ages Eligible for Study: | 20 Years to 90 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Responsible Party: | University of Miami, Bascom Palmer Eye Institute ( Wendy W. Lee ) |
Study ID Numbers: | 20070706 |
Study First Received: | October 15, 2008 |
Last Updated: | October 15, 2008 |
ClinicalTrials.gov Identifier: | NCT00773136 |
Health Authority: | United States: Institutional Review Board |
Bimatoprost Eyelash lengthening Prostaglandin Analogs Cosmetics |
Bimatoprost |
Therapeutic Uses Cardiovascular Agents Antihypertensive Agents Pharmacologic Actions |